Excess PCSK9 contributes to the degradation of LDL receptors (LDLR) in the liver, so LDL cholesterol levels in the blood increase and can worsen the risk of cardiovascular disease [3,17]. This evidence concerns the gene LDLR and cardiovascular disorder.